Your browser doesn't support javascript.
loading
Functional interactions between complex I and complex II with nNOS in regulating cardiac mitochondrial activity in sham and hypertensive rat hearts.
Wu, Yu Na; Sudarshan, Vidya K; Zhu, Shi Chao; Shao, Yong Feng; Kim, Sung Joon; Zhang, Yin Hua.
Affiliation
  • Wu YN; Yanbian University Hospital, Yanji, 133000, Jilin Province, China.
  • Sudarshan VK; Department of Physiology & Biomedical Sciences, Ischemic/Hypoxic Disease Institutes, Seoul National University, College of Medicine, Jongno-Gu, Seoul, Republic of Korea.
  • Zhu SC; Biomedical Engineering, School of Science and Technology, Singapore University of Social Sciences, Singapore, Singapore.
  • Shao YF; School of Electrical Engineering and Computing, University of Newcastle, Singapore, Singapore.
  • Kim SJ; Department of Cardiac Surgery, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang YH; Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, Fudan University, Shanghai, China.
Pflugers Arch ; 472(12): 1743-1755, 2020 12.
Article in En | MEDLINE | ID: mdl-32940784
ABSTRACT
Nitric oxide (NO) affects mitochondrial activity through its interactions with complexes. Here, we investigated regulations of complex I (C-I) and complex II (C-II) by neuronal NO synthase (nNOS) in the presence of fatty acid supplementation and the impact on left ventricular (LV) mitochondrial activity from sham and angiotensin II (Ang-II)-induced hypertensive (HTN) rats. Our results showed that nNOS protein was expressed in sham and HTN LV mitochondrial enriched fraction. In sham, oxygen consumption rate (OCR) and intracellular ATP were increased by palmitic acid (PA) or palmitoyl-carnitine (PC). nNOS inhibitor, S-methyl-l-thiocitrulline (SMTC), did not affect OCR or cellular ATP increment by PA or PC. However, SMTC increased OCR with PA + malonate (a C-II inhibitor), but not with PA + rotenone (a C-I inhibitor), indicating that nNOS attenuates C-I with fatty acid supplementation. Indeed, SMTC increased C-I activity but not that of C-II. Conversely, nNOS-derived NO was increased by rotenone + PA in LV myocytes. In HTN, PC increased the activity of C-I but reduced that of C-II, consequently OCR was reduced. SMTC increased both C-I and C-II activities with PC, resulted in OCR enhancement in the mitochondria. Notably, SMTC increased OCR only with rotenone, suggesting that nNOS modulates C-II-mediated OCR in HTN. nNOS-derived NO was partially reduced by malonate + PA. Taken together, nNOS attenuates C-I-mediated mitochondrial OCR in the presence of fatty acid in sham and C-I modulates nNOS activity. In HTN, nNOS attenuates C-I and C-II activities whereas interactions between nNOS and C-II maintain mitochondrial activity.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Electron Transport Complex I / Electron Transport Complex II / Nitric Oxide Synthase Type I / Hypertension / Mitochondria, Heart Type of study: Etiology_studies Language: En Journal: Pflugers Arch Year: 2020 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Electron Transport Complex I / Electron Transport Complex II / Nitric Oxide Synthase Type I / Hypertension / Mitochondria, Heart Type of study: Etiology_studies Language: En Journal: Pflugers Arch Year: 2020 Type: Article Affiliation country: China